Phase I trial of the anti-Lewis Y drug immunoconjugate BR96-doxorubicin in patients with Lewis Y-expressing epithelial tumors

Mansoor N. Saleh, Steve Sugarman, James Murray, Joy B. Ostroff, Diane Healey, Dennie Jones, Carol R. Daniel, Donna LeBherz, Hannah Brewer, Nicole Onetto, Albert F. LoBuglio

Research output: Contribution to journalArticlepeer-review

159 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase I trial of the anti-Lewis Y drug immunoconjugate BR96-doxorubicin in patients with Lewis Y-expressing epithelial tumors'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science